Exactly, rather do things properly than rush only for that to backfire. Plenty of medical companies have attempted to rush things through clinical trial processes (usually for the purpose of increasing the share price) only for it to backfire because they missed a crucial process and have to restart. Won't mention any names but I am sure anyone here who has spent time researching med stocks would know what I am talking about
Exactly, rather do things properly than rush only for that to...
-
- There are more pages in this discussion • 6,521 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.020(4.82%) |
Mkt cap ! $789.1M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 44.0¢ | 41.5¢ | $3.690M | 8.569M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66897 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 414256 | 15 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |